Literature DB >> 3413002

Endovascular papillary angioendothelioma in the spleen.

J A Katz1, D H Mahoney, L W Shukla, C W Smith, M V Gresik, H K Hawkins.   

Abstract

Endovascular papillary angioendothelioma is a rare vascular neoplasm originally described as involving the skin and subcutaneous tissues. No case has been reported to involve the spleen, although structurally similar splenic neoplasms have been reported under different names. A 5-year-old boy presented with isolated splenomegaly and was found to have endovascular papillary angioendothelioma of the spleen. Studies supported the suggestion that the endovascular papillary angioendothelioma manifests focal "high" endothelial differentiation.

Entities:  

Mesh:

Year:  1988        PMID: 3413002     DOI: 10.3109/15513818809022296

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  5 in total

1.  CASE REPORT Successful Treatment of a Rare Massive Dabska Tumor.

Authors:  Oliver S Eng; Gregory L Borah; Christopher J Gannon
Journal:  Eplasty       Date:  2013-09-10

2.  Dabska tumor (endovascular papillary angioendothelioma) of testis: a case report with brief review of literature.

Authors:  Alka Bhatia; Ritambra Nada; Yashwant Kumar; Prema Menon
Journal:  Diagn Pathol       Date:  2006-07-22       Impact factor: 2.644

3.  Intraosseous papillary intralymphatic angioendothelioma (PILA): one new case and review of the literature.

Authors:  Marco Gambarotti; Alberto Righi; Marta Sbaraglia; Giuseppe Bianchi; Piero Picci; Daniel Vanel; Angelo Paolo Dei Tos
Journal:  Clin Sarcoma Res       Date:  2018-01-30

4.  Papillary intralymphatic angioendothelioma: An extremely rare tumor.

Authors:  Güven Ozan Kaplan; Fethiye Damla Menku Özdemir; Diclehan Orhan; Ali Emre Aksu; Figen Özgür
Journal:  Jt Dis Relat Surg       Date:  2021-01-06

Review 5.  Unusual multifocal intraosseous papillary intralymphatic angioendothelioma (Dabska tumor) of facial bones: a case report and review of literature.

Authors:  Bin Li; Yang Li; Xiao-ying Tian; Zhi Li
Journal:  Diagn Pathol       Date:  2013-09-24       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.